TITLE:
      Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4
SUMMARY:
      The purpose of this study is to empirically test a series of medications to: 1) determine
      each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective
      dose range for each medication. In this study, amantadine is tested."
DETAILED DESCRIPTION:
      16-week participation plus a 2 weekk lead-in period. Participants are assigned randomly to
      placebo or amantadine. Participants attend group meeting 3 times/week
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F, ages 18-65. cocaine dependence according to DMS-IV criteria. Self-reported use within
        the last 30 days. Agreeable to conditions of the study and signed informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy, history of seizures. Pregnant
        and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hypnotics.
        Acute hepatitis. Other medical conditions that deem participation to be unsafe.
